共 128 条
[1]
Freifeld AG(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 e56-2266
[2]
Bow EJ(2006)Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Cancer 106 2258-611
[3]
Sepkowitz KA(2008)Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia J Clin Oncol 26 606-60
[4]
Boeckh MJ(2008)Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock—2008 Intensive Care Med 34 17-715
[5]
Ito JI(2013)Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline J Clin Oncol 31 794-340
[6]
Mullen CA(2004)Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study Oncol Nurs Forum 31 711-284
[7]
Raad II(2002)Neutropenic fever: one institution’s quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy Clin J Oncol Nurs 6 337-3051
[8]
Rolston KV(2011)Improving the immediate management of neutropenic sepsis in the UK: lessons from a national audit Br J Haematol 153 773-668
[9]
Young JH(2011)Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis Curr Oncol 16 280-435
[10]
Wingard JR(2000)The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients J Clin Oncol 18 3038-1495